Chad M. Robins, CEO and Chairman at Adaptive Biotechnologies Corp (ADPT), sold 524,998 shares at $15.99 ($8.3M) on 2026-02-27, disclosed to the SEC on 2026-03-03.
Seasonal sale ($8.3M) by CEO and Chairman — this insider has traded ADPT in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.99 | 182,891 | $2.9M | 35.1% |
| 2 | $15.82 | 289,024 | $4.6M | 55.0% |
| 3 | $15.49 | 50,703 | $785K | 9.4% |
| 4 | $16.15 | 2,380 | $38K | 0.5% |
| Total | $15.85 avg | 524,998 | $8.3M | 100% |
| Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |
| ADPT | SELL | 2026-02-04 | $2.3M | — | Filing → |
| ADPT | SELL | 2026-01-07 | $1.9M | — | Filing → |